Αποτελέσματα Αναζήτησης
21 Δεκ 2022 · BioNtech has dosed the first patient with its BNT163 herpes vaccine candidate designed to prevent genital lesions as part of a first-in-human Phase 1 clinical research study, the German...
Moderna is developing a vaccine using mRNA technology to treat the herpes simplex virus (HSV). There are two HSV virus types — HSV-1, the one I have, that affects the mouth, face and genitals...
14 Μαΐ 2019 · Development of one or more herpes simplex virus (HSV) vaccines is an important objective for sexual and reproductive health worldwide. WHO preferred product...
5 Μαρ 2024 · A leading global vaccine developer has announced that their investigational vaccine candidate for Herpes Simplex Virus (HSV) is undergoing a phase 1/2 clinical trial for the first time in Europe, England, and the United States.
4 Απρ 2024 · Herpes simplex viruses (HSV) are widely known to cause viral infections such as blisters around the face, and genital herpes usually affects the genital and buttocks area. Recent research suggests that HSV may also be linked to Alzheimer's and autoimmune diseases.
13 Μαΐ 2024 · Published May 13 in Nature Communications, Jerome and his Fred Hutch team report an encouraging step toward a gene therapy for herpes. The experimental gene therapy involves injecting into the blood a mixture of gene editing molecules that seek out where the herpes virus resides in the body.
6 Δεκ 2021 · Development of the therapeutic Shingrix vaccine for Herpes Zoster and a prophylactic vaccine for varicella zoster virus (VZV) has increased efforts for HSV vaccine due to similarities between the two viruses, especially with the establishment of latency (Heineman et al., 2019).
